[Amniotic fluid embolism during curettage for a pregnancy arrest. Case report].
Amniotic fluid embolism is always a serious complication during the peripartum period. We report the case of an amniotic fluid embolism during curettage for a pregnancy arrest at 13 weeks. The diagnosis was confirmed by the presence of epithelial cells into the maternal blood.
Fekhkhar
K
K
Département d'anesthésie-réanimation chirurgicale, CHU Charles-Nicolle, 1, rue de Germont, 76031 Rouen cedex, France.
Rachet
B
B
Gillet
R
R
Provost
D
D
Lalo
J-P
JP
Rieu
M
M
Compère
V
V
Roussel
F
F
Marpeau
L
L
Dureuil
B
B
D000027:Abortion, Incomplete / Q000601:surgery*; D000328:Adult; D000707:Anaphylaxis / Q000175:diagnosis; D000990:Antithrombin III / Q000627:therapeutic use; D016913:Blood Component Transfusion; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004107:Dilatation and Curettage; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000175:diagnosis / Q000209:etiology*; D004619:Embolism, Amniotic Fluid / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy; D005260:Female; D005440:Fluid Therapy; D005780:Gelatin / Q000627:therapeutic use; D006489:Hemostatic Techniques; D006801:Humans; D007431:Intraoperative Complications / Q000175:diagnosis* / Q000628:therapy; D010952:Plasma Substitutes / Q000627:therapeutic use; D011183:Postoperative Complications / Q000628:therapy*; D011247:Pregnancy; D012121:Respiration, Artificial; D012771:Shock, Hemorrhagic / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D013386:Succinates / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000209:etiology*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D010952:Plasma Substitutes; D013386:Succinates; D014662:Vasoconstrictor Agents; C060085:succinylated gelatin; D005780:Gelatin; D000990:Antithrombin III